Revvity Inc. logo

Revvity Inc. (0KHE)

Market Closed
3 Mar, 15:30
LSE LSE
$
94. 30
-1.2
-1.26%
$
- Market Cap
- P/E Ratio
0.28% Div Yield
1,299 Volume
- Eps
$ 95.5
Previous Close
Day Range
91.91 94.72
Year Range
79.5 138.9
Want to track 0KHE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0KHE earnings report is expected in 55 days (27 Apr 2026)

Summary

0KHE closed today lower at $94.3, a decrease of 1.26% from yesterday's close, completing a monthly decrease of -9.86% or $10.31. Over the past 12 months, 0KHE stock lost -3.53%.
0KHE pays dividends to its shareholders, with the most recent payment made on Feb 06, 2026. The next announced payment will be in In 2 months on May 08, 2026 for a total of $0.07.
The last earnings report, released on Feb 02, 2026, missed the consensus estimates by -1.58%. On average, the company has fell short of earnings expectations by -1.13%, based on the last three reports. The next scheduled earnings report is due on Apr 27, 2026.
Revvity Inc. has completed 4 stock splits, with the recent split occurring on Jun 04, 2001.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

0KHE Chart

Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Seekingalpha | 1 day ago
Revvity: Close To A Buy, Not Quite There

Revvity: Close To A Buy, Not Quite There

Diagnostics is driving Revvity, Inc. growth, especially outside China. Signals software a standout: high-teens growth, SaaS ARR +40%. China immunodiagnostics and NIH funding remain key drags.

Seekingalpha | 3 weeks ago
Here's Why Revvity (RVTY) is a Strong Momentum Stock

Here's Why Revvity (RVTY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 4 weeks ago

Revvity Inc. (0KHE) FAQ

What is the stock price today?

The current price is $94.30.

On which exchange is it traded?

Revvity Inc. is listed on LSE.

What is its stock symbol?

The ticker symbol is 0KHE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.28%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.02.

When is the next earnings date?

The next earnings report will release on Apr 27, 2026.

Has Revvity Inc. ever had a stock split?

Revvity Inc. had 4 splits and the recent split was on Jun 04, 2001.

Revvity Inc. Profile

Professional Services Industry
Industrials Sector
Prahlad R. Singh CEO
LSE Exchange
US7140461093 ISIN
US Country
11,000 Employees
17 Apr 2026 Last Dividend
4 Jun 2001 Last Split
- IPO Date

Overview

Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.

Products and Services

Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:

  • AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
  • chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
  • JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
  • Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
  • T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.

Contact Information

Address: 940 Winter Street
Phone: 781 663 6900